Literature DB >> 29637243

[Surgical strategies for small sporadic neuroendocrine pancreatic tumors].

K Holzer1.   

Abstract

Small (<2 cm) sporadic neuroendocrine pancreatic neoplasms (pNENs) are a heterogeneous group of neoplasms, which can be separated into functionally active or non-functional tumors. Functionally active pNENs release various hormones, such as insulin, gastrin, glucagon and vasoactive intestinal hormones and therefore lead to severe symptoms independent of their size. The main symptoms include hypoglycemia, coma (insulinoma), diarrhea (gastrinoma, VIPoma), intestinal ulcers (gastrinoma) and hyperglycemia (glucagonoma). Asymptomatic inactive pNENs do not cause a hormonal syndrome even though in immunohistochemistry they are positive for various hormones and endocrine markers (e.g. chromogranin and synaptophysin). Non-active small pNENs are increasingly being found because of the widespread use of high-resolution imaging and are named incidental pNENs. The current therapy algorithms of small functionally active and non-functional pNENs are very different and include besides non-operative management and surveillance (wait and see strategy) of non-active pNENs (G1, low G2), all minimally invasive, open and robotic techniques of pancreas resection. Until today almost all recommendations of surgical and nonsurgical therapy algorithms have been established based on retrospective data.

Entities:  

Keywords:  Enucleation; Laparoscopy; Lymph node dissection; Robotic assistance; Wait and see strategy

Mesh:

Year:  2018        PMID: 29637243     DOI: 10.1007/s00104-018-0632-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  27 in total

1.  Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases.

Authors:  Alessandro Zerbi; Vanessa Capitanio; Letizia Boninsegna; Claudio Pasquali; Guido Rindi; Gianfranco Delle Fave; Marco Del Chiaro; Riccardo Casadei; Massimo Falconi
Journal:  Langenbecks Arch Surg       Date:  2010-09-21       Impact factor: 3.445

2.  Robotic-Assisted Approach Improves Vessel Preservation in Spleen-Preserving Distal Pancreatectomy.

Authors:  Sabine Eckhardt; Christoph Schicker; Elisabeth Maurer; Volker Fendrich; Detlef K Bartsch
Journal:  Dig Surg       Date:  2016-05-04       Impact factor: 2.588

3.  Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Sébastien Gaujoux; Stefano Partelli; Frédérique Maire; Mirko D'Onofrio; Béatrice Larroque; Domenico Tamburrino; Alain Sauvanet; Massimo Falconi; Philippe Ruszniewski
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

Review 4.  Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms.

Authors:  S Partelli; R Cirocchi; S Crippa; L Cardinali; V Fendrich; D K Bartsch; M Falconi
Journal:  Br J Surg       Date:  2016-10-05       Impact factor: 6.939

5.  Resection strategies for neuroendocrine pancreatic neoplasms.

Authors:  F M Watzka; C Laumen; C Fottner; M M Weber; A Schad; H Lang; T J Musholt
Journal:  Langenbecks Arch Surg       Date:  2012-11-11       Impact factor: 3.445

6.  Risk factors for postoperative pancreatic fistulization subsequent to enucleation.

Authors:  Céline Brient; Nicolas Regenet; Laurent Sulpice; Laurent Brunaud; Stéphanie Mucci-Hennekine; Nicolas Carrère; Jenifer Milin; Ahmet Ayav; Bernard Pradere; Antoine Hamy; Laurent Bresler; Bernard Meunier; Eric Mirallié
Journal:  J Gastrointest Surg       Date:  2012-08-08       Impact factor: 3.452

7.  Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Authors:  Yassar M Hashim; Kathryn M Trinkaus; David C Linehan; Steven S Strasberg; Ryan C Fields; Dengfeng Cao; William G Hawkins
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

8.  Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.

Authors:  Alberto Larghi; Gabriele Capurso; Antonella Carnuccio; Riccardo Ricci; Sergio Alfieri; Domenico Galasso; Francesca Lugli; Antonio Bianchi; Francesco Panzuto; Laura De Marinis; Massimo Falconi; Gianfranco Delle Fave; Giovanni Battista Doglietto; Guido Costamagna; Guido Rindi
Journal:  Gastrointest Endosc       Date:  2012-09       Impact factor: 9.427

9.  Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.

Authors:  Eric J Kuo; Ronald R Salem
Journal:  Ann Surg Oncol       Date:  2013-06-15       Impact factor: 5.344

10.  Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.

Authors:  Karl Y Bilimoria; Mark S Talamonti; James S Tomlinson; Andrew K Stewart; David P Winchester; Clifford Y Ko; David J Bentrem
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

View more
  1 in total

1.  Amyloid-Rich Pancreatic Neuroendocrine Tumors: a Potential Diagnostic Pitfall in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology (EUS-FNAC).

Authors:  Alessandro Gambella; Enrico Costantino Falco; Jasna Metovic; Francesca Maletta; Claudio De Angelis; Roberta Maragliano; Silvia Uccella; Donatella Pacchioni; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-06       Impact factor: 3.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.